Skip to main content

Table 3 Multivariate analysis for prognostic factors

From: Evaluation of the efficacy of prophylactic extended field irradiation in the concomitant chemoradiotherapy treatment of locally advanced cervical cancer, stage IIIB in the 2018 FIGO classification

SubjectHRCI 95%P value
OS
Age0.3310.160–0.6830.003
Tumor size0.2620.098–0.6990.007
EQD2(point A)2.5301.159–5.5210.036
DFS
Age0.4620.232–0.9200.028
EFI1.9271.000–3.7140.050
EQD2(point A)2.9491.379–6.3060.005
LCR
Tumor size0.0910.011–0.7450.026
Age0.2660.084–0.8430.024
EQD2(point A)5.5781.795–17.3320.003
OFRFS
Concurrent chemotherapy2.7381.248–6.0090.012
EFI3.2871.369–7.8920.008